Items Tagged ‘#liquid biopsies’
November 30, 2017
3 ways Mayo Clinic is advancing individualized approaches to breast cancer treatment
By Sharon Rosen 
By Sharon Rosen and Susan Buckles Approximately one out of eight American women will develop breast cancer during their lifetime. In the U.S., it is estimated that more than 315,000 women will be diagnosed this year with breast cancer. While statistics show fewer women are dying from the disease, breast cancer still remains the second […]
Tags: #blood tests, #breast cancer screening, #cancer detection, #cancer treatment, #Dr. Ciara O'Sullivan, #Dr. Minetta Liu, #genetic factors, #individualized therapy, #liquid biopsies, #xenografts, Beauty Study, breast cancer
October 11, 2017
#CIMCon17 – precision medicine for smoking cessation, rare diseases and cancer screening
By Sharon Rosen
Ever wonder why some people can quit smoking while others try repeatedly without success? The answer may be related to your genetic makeup. Studies have shown that 70 percent of smokers want to quit, but only three percent are successful each year. That’s according to Rachel Tyndale, Ph.D., professor of Pharmacology and Psychiatry, Centre for […]
Tags: #cell-free DNA testing, #Dr. Minetta Liu, #Dr. Muhammed Murtaza, #Dr. Rachel Tyndale, #Dr. Richard Williams, #Dr. William Gahl, #liquid biopsies, #pharmacogenomics testing, #rare diseases, #rare genetic disorders, #smoking cessation, #Undiagnosed Disease Network
October 10, 2017
By Sharon Rosen
“Genomic medicine is already part of mainstream medical care,” says A. Keith Stewart, M.B., Ch.B., in his opening remarks at the sixth Individualizing Medicine 2017: Advancing Care Through Genomics, a conference hosted by the Mayo Clinic Center for Individualized Medicine. Dr. Stewart, the Carlson and Nelson director of the Center for Individualized Medicine, kicked off the conference yesterday […]
Tags: #cell-free DNA testing, #CIMCon17, #Dr. David Ledbetter, #Geisinger Health System, #genomic testing, #Individualizing Medicine Conference 2017, #liquid biopsies, #MyCode Community Health Initiative, #rare diseases, cancer, center for individualized medicine, Dr. Keith Stewart
October 3, 2017
Liquid biopsies: detecting and treating cancer sooner
By Sharon Rosen
What if a blood test could discover cancer before a tumor first appears or before the first signs of cancer recurrence are seen by a radiology study? In fact, these types of blood tests, often called liquid biopsies, are already changing clinical care for patients with cancer. Researchers and physicians in Mayo Clinic Center for […]
Tags: #blood tests, #cancer treatment, #cell-free DNA testing, #CIMCon17, #circulating tumor cells, #Dr. Minetta Liu, #Individualizing Medicine 2017, #liquid biopsies, Advanced Cancer, breast cancer, cancer, cancer screening
August 2, 2017
Expanding the search: genetic testing reveals new targets, treatment options for cancer patients
By Sharon Rosen
Researchers in Mayo Clinic Center for Individualized Medicine are using new genetic tests developed at Mayo Clinic to find more effective therapies for cancer patients who have not benefited from standard treatment and are running out of options. The new tests look at a broader range of genetic characteristics than many standard tests. As a […]
Tags: #3-d models, #boimarker, #CIMCon17, #DNA analysis, #Dr. Aaron Mansfield, #Dr. George Vasmatizis, #genetic variations, #liquid biopsies, center for individualized medicine, Genetic Testing, genomics, Lung Cancer
October 11, 2016
New biomarker discovery approaches to improve patient care
Biomarkers are an important measure of health and disease that can help doctors understand how to more effectively treat cancerous tumors. The topic of TIGER-Bio, a new approach to biomarker discovery, came into the spotlight in a workshop on the final morning of Individualizing Medicine 2016: Advancing Care through Genomics, The session, TIGER-Bio: The Integrated […]
Tags: #3-D genomic models, #bomarker discovery, #Dr. Mark Truty, #Dr. Minetta Liu, #Dr. Mitesh Borad, #liquid biopsies, #xenograph models, Cancer Research, center for individualized medicine, DNA Sequencing, Dr. George Vasmatzis, Genomic Research